Home/Synairgen/Joseph Colliver
JC

Joseph Colliver

Chief Executive Officer

Synairgen

Synairgen Pipeline

DrugIndicationPhase
SNG001Severe Viral Lung Infections in Mechanically Ventilated PatientsPhase 2